Envision Pharma Group
AI-powered real-world evidence: Strategically enhancing value and access
Real-world evidence (RWE) is a critical tool for understanding how medicines perform in diverse patient populations and real-world settings. However,...
Aug 22nd • 5 mins read
Envision Pharma Group
Empowering people to drive medical affairs performance with AI
Artificial intelligence (AI) is transforming the pharmaceutical industry and continues to be a key topic of discussion in the field....
Aug 14th • 5 mins read
Envision Pharma Group
Medical affairs: The power behind redefining commercialization
In March 2024, Envision Pharma Group held a Medical Affairs Professional Society (MAPS) Americas roundtable with leaders discussing the role...
Aug 2nd • 3 mins read
Envision Pharma Group
Patient involvement: A must-have in medicine development, but is it being overlooked in a cost-constrained environment?
The life sciences industry is in a constant state of advancement, bringing more and more groundbreaking medicines, cutting-edge technologies, and...
May 9th • 5 mins read
